Get the Stockscreener App
8.19
6.78%
0.52
Cullinan Therapeutics Inc stock is traded at $8.19, with a volume of 627.40K.
It is up +6.78% in the last 24 hours and up +0.99% over the past month.
Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.
See More
Previous Close:
$7.67
Open:
$7.76
24h Volume:
627.40K
Relative Volume:
1.86
Market Cap:
$483.82M
Revenue:
-
Net Income/Loss:
$-153.16M
P/E Ratio:
-2.2195
EPS:
-3.69
Net Cash Flow:
$-134.48M
1W Performance:
+6.92%
1M Performance:
+0.99%
6M Performance:
-9.30%
1Y Performance:
-54.14%
1-Day Range:
$7.76
$8.32
1-Week Range:
$7.44
$8.32
52-Week Range:
$6.85
$19.89
Cullinan Therapeutics Inc Stock (CGEM) Company Profile
Name
Cullinan Therapeutics Inc
Sector
Industry
Phone
617-410-4650
Address
ONE MAIN STREET, CAMBRIDGE
Compare CGEM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CGEM
Cullinan Therapeutics Inc
|
8.19 | 469.64M | 0 | -153.16M | -134.48M | -3.69 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Cullinan Therapeutics Inc Stock (CGEM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-11-25 | Resumed | Stifel | Buy |
| Oct-24-24 | Initiated | UBS | Buy |
| May-01-24 | Initiated | Stifel | Buy |
| Apr-15-24 | Initiated | William Blair | Outperform |
| Feb-15-24 | Initiated | Wedbush | Outperform |
| Jun-15-23 | Initiated | TD Cowen | Outperform |
| Nov-21-22 | Initiated | BTIG Research | Buy |
| Apr-27-21 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Feb-02-21 | Initiated | Evercore ISI | Outperform |
| Feb-02-21 | Initiated | Morgan Stanley | Equal-Weight |
| Feb-02-21 | Initiated | SVB Leerink | Outperform |
| Feb-01-21 | Initiated | H.C. Wainwright | Buy |
View All
Cullinan Therapeutics Inc Stock (CGEM) Latest News
Cullinan Therapeutics Inc. Matches Institutional Buying Filter2025 Price Targets & Short-Term High Return Ideas - beatles.ru
Is Cullinan Therapeutics Inc. meeting your algorithmic filter criteriaTrade Entry Report & Risk Managed Investment Strategies - Newser
Will Cullinan Therapeutics Inc. see short term momentumBond Market & AI Driven Price Forecasts - Newser
Will Cullinan Therapeutics Inc. continue its uptrendOptions Play & Technical Pattern Alert System - Newser
Live market analysis of Cullinan Therapeutics Inc.July 2025 News Drivers & Smart Money Movement Alerts - Newser
What’s the recovery path for long term holders of Cullinan Therapeutics Inc.2025 Volatility Report & Free Weekly Watchlist of Top Performers - Newser
Is it too late to sell Cullinan Therapeutics Inc.Global Markets & Risk Controlled Daily Plans - Newser
When is the best time to exit Cullinan Therapeutics Inc.July 2025 WrapUp & AI Powered Buy/Sell Recommendations - Newser
What high frequency data says about Cullinan Therapeutics Inc.Quarterly Trade Review & Free Community Supported Trade Ideas - Newser
How to build a custom watchlist for Cullinan Therapeutics Inc.Quarterly Trade Summary & Daily Volume Surge Trade Alerts - Newser
Technical signs of recovery in Cullinan Therapeutics Inc.Options Play & High Win Rate Trade Tips - Newser
Applying Elliott Wave Theory to Cullinan Therapeutics Inc.Earnings Recap Report & Low Drawdown Investment Ideas - Newser
Using RSI to spot recovery in Cullinan Therapeutics Inc.Layoff News & Verified Momentum Stock Alerts - Newser
How Cullinan Therapeutics Inc. stock performs during market volatilityJuly 2025 Intraday Action & Low Drawdown Investment Strategies - Newser
Quant Funds Rotate Into Cullinan Therapeutics Inc. StockWeekly Trade Report & Weekly Market Pulse Alerts - 선데이타임즈
Cullinan Therapeutics Inc. Stages Intraday Comeback — Trend ChangeJuly 2025 Final Week & Safe Entry Momentum Stock Tips - classian.co.kr
Using data models to predict Cullinan Therapeutics Inc. stock movementEarnings Summary Report & Fast Moving Trade Plans - Newser
Cullinan Therapeutics Inc. stock trend outlook and recovery pathJuly 2025 Levels & Weekly High Conviction Ideas - Newser
Market reaction to Cullinan Therapeutics Inc.’s recent news2025 Geopolitical Influence & Community Consensus Trade Signals - Newser
Is Cullinan Therapeutics Inc. stock poised for growthEarnings Trend Report & Precise Swing Trade Entry Alerts - Newser
Is Cullinan Therapeutics Inc. showing signs of accumulationMarket Movement Recap & Technical Entry and Exit Tips - Newser
Does Cullinan Therapeutics Inc. fit your quant trading modelWeekly Trade Summary & AI Optimized Trading Strategy Guides - Newser
Short Interest Drops in Cullinan Therapeutics Inc. After RallyJuly 2025 Recap & Fast Moving Stock Watchlists - metal.it
What is Cullinan Therapeutics Inc.’s book value per shareJuly 2025 Movers & High Accuracy Trade Alerts - 선데이타임즈
How to track smart money flows in Cullinan Therapeutics Inc.July 2025 Drop Watch & Comprehensive Market Scan Insights - Newser
Real time social sentiment graph for Cullinan Therapeutics Inc.Market Activity Recap & Weekly Sector Rotation Insights - Newser
Is Cullinan Therapeutics Inc. stock reversal real or fakeGDP Growth & Step-by-Step Trade Execution Guides - Newser
Why Cullinan Therapeutics Inc. stock attracts strong analyst attentionJuly 2025 Drop Watch & Long-Term Safe Return Strategies - Newser
How to integrate Cullinan Therapeutics Inc. into portfolio analysis tools2025 Pullback Review & Risk Managed Trade Strategies - Newser
Using Ichimoku Cloud for Cullinan Therapeutics Inc. technicals2025 Momentum Check & Low Drawdown Trading Strategies - Newser
Is Cullinan Therapeutics Inc. exposed to political riskPortfolio Gains Report & Free Expert Approved Momentum Trade Ideas - thegnnews.com
Cullinan Therapeutics Inc Stock (CGEM) Financials Data
Revenue
Net Income
Cash Flow
EPS
Cullinan Therapeutics Inc Stock (CGEM) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| AHMED NADIM | President and CEO |
Feb 25 '25 |
Sale |
8.53 |
12,529 |
106,872 |
430,621 |
| Michaelson Jennifer | Chief Scientific Officer |
Feb 25 '25 |
Sale |
8.53 |
3,756 |
32,039 |
142,004 |
| SUMER JACQUELYN L | Chief Legal Officer |
Feb 25 '25 |
Sale |
8.53 |
3,756 |
32,039 |
136,895 |
| Michaelson Jennifer | Chief Scientific Officer |
Jan 06 '25 |
Sale |
12.51 |
4,000 |
50,040 |
95,760 |
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):